Lyra Therapeutics' Series A - II Round

Lyra Therapeutics raised a round of funding on June 01, 2015.

Lyra Therapeutics, fka 480 Biomedical, is a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, offering an alternative to conve…

Articles about Lyra Therapeutics' Series A - II Round: